Laryngeal Stents Market

Laryngeal Stents Market Outlook (2022-2027)

The global laryngeal stents market currently accounts for a valuation of US$ 53 million and is expected to reach US$ 75 million by the end of 2027. Worldwide demand for laryngeal stents is predicted to increase at a high-value CAGR of 7.1% from 2022 to 2027.

Sales of self-expandable stents are expected to increase faster at a CAGR of 7.7% over the study period. Self-expandable stents are widely used since they are simple to implant and don't require the use of general anesthesia.

Report Attributes	Details
Laryngeal Stents Market Size (2022)	US$ 53 Million
Projected Market Value (2027)	US$ 75 Million
Global Market Growth Rate (2022-2027)	7.1% CAGR
Market Share of Self-expandable Stents	60%
Key Companies Profiled	Medtronic Abbott BIOTRONIK B. Braun Terumo Corporation STENTYS SA MicroPort Scientific Corporation. Meril Life Sciences Pvt. Ltd. Vascular Concept. W. L. Gore & Associates, Inc. Translumina. JOTEC GmbH Lombard Medical Xcell Medical Group Cardinal Health. Cook Getinge AB

Sales Analysis of Laryngeal Stents (2017-2021) Vs Market Estimations (2022-2027)

“Rising Prevalence of Several Chronic & Inflammatory Disorders Driving Demand for Laryngeal Stents”

According to Fact.MR, a market research and competitive intelligence provider, worldwide sales of laryngeal stents are projected to increase rapidly at a CAGR of 7.1% from 2022 to 2027.

The market for laryngeal stents is expanding as a result of factors such as the increasing prevalence of cardiovascular diseases, increased focus on medical device research and development expertise and adoption of cutting-edge healthcare technologies, an ever-increasing geriatric population base, and rising investments in the development of healthcare infrastructure, particularly in developing economies.

The medical devices for airway management known as laryngeal stents are used to strengthen the laryngeal muscles. These stents are utilized to widen airways that have become narrowed due to lung cancer, tuberculosis, infections, lymphoma, or other inflammatory disorders.

One of the key reasons promoting the growth of the market is the increase in government initiatives to support the construction of healthcare infrastructure. Another factor influencing market expansion is the increasing accessibility of minimally-invasive procedures along with the rising frequency of numerous chronic and inflammatory disorders.

Other significant aspects that will contribute to the expansion of the arterial stents market are the rise in medical tourism, demand for endovascular stents, the desire for customized lung stents, and the rapid development of biodegradable and drug-eluting stents.

Why is the Popularity of Laryngeal Stents Rising at a Rapid Pace?

“Rising Demand for Minimally-invasive Surgeries for Chronic Respiratory Disorders”

The global market for laryngeal stents is expected to expand as a result of innovations in laryngeal stents that can offer actual information on the respiratory tract using technologies such as IoT and data science. The need for laryngeal stents has expanded globally due to the increasing number of patients with emphysema or chronic bronchitis.

Patients undergoing minimally-invasive operations for respiratory disorders recover more quickly, experience fewer difficulties, spend less time in the hospital, and lose less blood. As a result, the demand for laryngeal stents is increasing due to the rapid adoption of bronchoscopy, a minimally-invasive, non-surgical process for placing stents.

Numerous improvements in minimally-invasive techniques are also increasing the number of people who favor them for the treatment of breathing issues.

Lung cancer is becoming more common, which has increased the use of minimally-invasive procedures to avoid suffering. Patients who have congenital cystic adenomatoid abnormalities that make breathing difficult choose to have stents placed. As a result, the use of airway stents is rapidly increasing, which is driving up the need for lung stents. In addition, placing a lung stent has a lower risk of problems and is more affordable than more traditional operations.

Demand for laryngeal stents is projected to increase over the coming years due to the increasing prevalence of these disorders attributed to a sedentary lifestyle and a polluted environment. The market is expanding even more as a result of rising R&D expenditures by both public and private entities for the creation of non-vascular stents.

With ageing, a person's immune system deteriorates. Because of this, developing various ailments is more likely as the older population grows. Chronic respiratory disorders are more common and have an increased incidence since the senior population is growing quickly. This is hence expected to fuel the need for laryngeal stenting devices over the projection period.

How Can Market Growth Be Hampered to Some Extent?

“Availability of Alternative Therapies & Limited Reimbursement Policies”

The availability of alternative therapies and the high price of the recommended treatments may slow market expansion. The market is anticipated to face difficulties due to a lack of medical specialists, particularly in developing and undeveloped countries, and growing concerns about the risks related to stents.

Government-imposed strict rules on product approval and limited reimbursement policies are expected to hamper laryngeal stent systems market expansion over the coming years.

How Can Start-ups Establish Their Position in the Laryngeal Stents Industry?

“Emerging Market Players Can Offer Advanced Solutions that Enhance Patient Outcomes”

New companies are creating stents that adjust and follow the anatomy of each patient. For stenting treatments, emerging market players provide advanced solutions that enhance patient outcomes.

• Thoracent, a start-up based in the U.S., creates pulmonology-related medical equipment called BONASTENT. It is a self-expanding metallic esophageal stent. It has a nitinol hook and cross-wire structure that allows it to conform to the anatomy of the patient. Additionally, it has the best radial and returning forces for great conformability. Tracheobronchial stents and other endoscopic equipment are also offered by the company.

Which Region is Expected to Lead Market Expansion Going Forward?

“Extensive Implementation of Clinical Guidelines Released by Healthcare Organizations in North America”

North America dominates the laryngeal stents market due to the existence of favorable reimbursement rules, an improved healthcare infrastructure, and rising demand for coronary stents.

The market expansion is being driven by a properly integrated network of public and commercial hospitals, high consumer knowledge of laryngeal stents, and a rise in government measures to deliver improved healthcare services.

Some of the main drivers of the market growth include the significant presence of laryngeal stent manufacturers, high awareness of respiratory diseases among surgeons, favorable government initiatives, and extensive implementation of clinical guidelines released by healthcare organizations.

Country-wise Insights

How is the Market for Laryngeal Stents Evolving in the U.S.?

“Emergence of Unique & Innovative Laryngeal Stents in the U.S.”

Demand for laryngeal stents in the United States is consistently high due to the rising prevalence of respiratory illnesses. The market demand is being fueled by the existence of prominent market players working on the creation and introduction of unique and innovative laryngeal stents.

Growth of the market in the United States is being driven by modern healthcare services, the presence of several large hospitals, the rising adoption of medical devices, and the growing usage of tracheal stents.

What’s Driving Demand for Laryngeal Stents in China?

“High R&D Investments by International Firms in China”

The laryngeal stents market in China is anticipated to race ahead at a CAGR of 10% from 2022 to 2027.

Laryngeal stent manufacturing is increasingly being outsourced, which is expected to boost market growth in China throughout the forecast period. High R&D investments by international firms in the country also act as a growth-promoting factor.

The market is expanding in China due to factors such as the increased prevalence of lung cancer, an ageing population, the expansion of hospitals and clinics, and the availability of labor at low costs for production.

Category-wise Insights

Which Type of Laryngeal Stents Will See a Rise in Sales?

“Growing Usage of Self-expandable Stents to Treat Several Respiratory Issues Driving Market Demand”

Based on product, the laryngeal stents market is divided into (self-expandable stents, non-expandable stents, and balloon-expandable stents. Self-expandable stents account for 60% share of the global laryngeal stents market.

Self-expandable stents reduce the risk of numerous problems and are simple to remove. In addition, more interventional pulmonologists are using self-expanding stents. Because they are so simple to put, self-expandable stents are frequently utilized to treat malignant airway blockage.

In the long-term management of benign tracheobronchial stenosis, self-expandable stents are both safe and efficient. Patients with malignant airway disease can also benefit from the symptom relief provided by these stents.

Additionally, self-expandable stents are utilized to treat tracheobronchomalacia, tracheal burns, lung transplantation complications, and extrinsic tracheal tightness.

Which End User is Expected to Generate High Revenue for Market Players?

“Wide Availability of Qualified Medical Personnel in Hospitals Driving Market Growth”

The laryngeal stents market is segmented into ambulatory surgery centers and hospitals based on end user. The largest share of the global market is held by hospitals due to the increased admission of patients with chronic illnesses.

The availability of a significant number of qualified medical personnel in hospitals has led to an increase in the number of patient admissions. An increase in patients is being caused by a favorable reimbursement scenario for respiratory problem procedures in hospitals. The use of laryngeal stents in hospitals has grown as a result of the growing number of public hospitals offering patients treatment that is both effective and affordable.

Hospitals are performing an increasing number of operations and bronchoscopies. Governments in various countries are also providing insurance and financial assistance for medical care, which is encouraging more individuals to seek treatment in hospitals for serious illnesses

Additionally, a strong infrastructure helps with effective surgical treatments. Growing government activities targeted at enhancing safety and minimizing unfavorable incidents are driving the demand for laryngeal stents in hospitals.

Competitive Landscape

Major firms have employed techniques such as mergers & acquisitions and strategic alliances to acquire a competitive edge in the market. Key companies are putting more emphasis on creating advanced products that are more accurate and effective.

For instance :

• In 2020, self-expanding metal stents (SEMS) called HANAROSTENT Esophagus TTS were created by the Massachusetts Institute of Technology and made available solely by Olympus in the United States.

Laryngeal Stents Industry Research Segmentation

• By Product :

  • Self-expandable Stents
  • Non-expandable Stents
  • Balloon-expandable Stents

• By End User :

  • Hospitals
  • Ambulatory Surgery Centers

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa